Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study
1 other identifier
observational
110
1 country
1
Brief Summary
Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2020
CompletedFirst Submitted
Initial submission to the registry
March 16, 2021
CompletedFirst Posted
Study publicly available on registry
March 19, 2021
CompletedMarch 19, 2021
March 1, 2021
1.4 years
March 16, 2021
March 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Patient reported outcome score: ASES
American Shoulder and Elbow Society (ASES) Score
until august 2020
Complication rate
postoperative complications requiring surgical intervention
until august 2020
Quality adjusted life year (QALY)
The quality adjusted life year (QALY) ) is a well-established indicator of the life quality for the remaining years and was calculated as the years of life following the operation, multiplied by the utility value, for the current study, defined as the postoperative American Shoulder and Elbow Surgeons Shoulder Score (ASES) score (0-1 points) at last follow-up.
until august 2020
Mortality
Survivership
until august 2020
Patient reported outcome score: QuickDASH
Quick Disabilities of the arm, shoulder and hand (DASH) Score,
until august 2020
Patient reported outcome score: VAS
Visual analog score (VAS)
until august 2020
Secondary Outcomes (1)
Patient demographics
at time of surgery
Study Arms (2)
Elective cases
Patients, who received a RTSA for degenerative reasons like cuff arthropathy or osteoarthritis
Fracture cases
Patients, who received a RTSA for a proximal humerus fracture
Interventions
Implantation of a Reverse Total Shoulder Arthroplasty
Eligibility Criteria
Patients who have already exceeded their life-expectancy (83 years in Switzerland)
You may qualify if:
- Patients older than 83 years at time of surgery
- Patients who received a reverse total shoulder arthroplasty
You may not qualify if:
- Patients younger than 83 years at time of surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bürgerspital Solothurn
Solothurn, 4500, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Mai Lan Dao Trong, MD
Bürgerspital Solothurn
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician shoulder and elbow surgery
Study Record Dates
First Submitted
March 16, 2021
First Posted
March 19, 2021
Study Start
March 24, 2019
Primary Completion
August 4, 2020
Study Completion
December 21, 2020
Last Updated
March 19, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share